Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of TVRD will decline by -4.68% over the next 2 Weeks and hit $4.34 by Friday, January 23, 2026. In that time frame, TVRD's share price is expected to range between $4.14 and $4.54.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jan 23, 2026 | 4.30 | 4.50 | 4.70 |
| Jan 22, 2026 | 4.39 | 4.58 | 4.78 |
| Jan 21, 2026 | 4.30 | 4.49 | 4.68 |
| Jan 20, 2026 | 4.26 | 4.45 | 4.65 |
| Jan 19, 2026 | 4.29 | 4.47 | 4.68 |
| Jan 16, 2026 | 4.33 | 4.53 | 4.71 |
| Jan 15, 2026 | 4.43 | 4.61 | 4.80 |
| Jan 14, 2026 | 4.33 | 4.52 | 4.70 |
| Jan 13, 2026 | 4.28 | 4.48 | 4.68 |
| Jan 12, 2026 | 4.30 | 4.49 | 4.67 |
TVRD shares rose +7.57% in Friday, January 9, 2026's trading session, rising from a previous close of $4.23 to move at $4.55. The stock demonstrated notable intraday movement (see TVRD's key stats for a full breakdown), fluctuating between $4.01 and $4.70, a +17.21% trading range. While recent weeks have seen some volatility, TVRD has managed to secure a +9.90% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 301.75K shares changing hands, 110.64K more than the previous session. This amounted to $1.37M in total market activity.
Will TVRD Continue Its Upward Trend?
According to analyst ratings and projections for TVRD, Tvardi Therapeutics, Inc. shares are anticipated to increase by +3.09%, potentially reaching $4.70 per share by January 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for TVRD. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the TVRD stock forecast, now is a good time to buy TVRD stock because its current trading price is +1.08% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on TVRD covering social and institutional perspectives.
TVRD Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into TVRD's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.02% to 65.70%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.39%, suggests a neutral medium-term outlook. Meanwhile, the 100-day RSI, at 86.80%, indicates a bearish outlook for the long term. Insights into TVRD's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Tvardi Therapeutics Short-Term Forecasts
TVRD Forecast For Next 5 Days
Our algorithm anticipates Tvardi Therapeutics (TVRD) stock could hit $0.72 by Jan 08, 2026. This represents a -84.18% fall from today's price, following a -1.63% change over the past five days.
TVRD Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Tvardi Therapeutics, Inc. (TVRD) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.42, which would mean a -90.77% decrease from the current price of $4.55. Projections for this period range from a high of $4.34 to a low of $0.00.
TVRD Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Tvardi Therapeutics's price over the next three months point to a rise. TVRD stock is expected to peak at $110.64 on Mar 06, 2026 before potentially dipping to $50.11 on Mar 31, 2026. On average, TVRD is likely to trade around $70.11 in the coming 90 days.
Tvardi Therapeutics Stock Forecast 2025
Based on our predictive models, Tvardi Therapeutics (TVRD) is expected to trade between $0.00 and $110.64 throughout 2026. This would result in an average price of $54.87, potentially offering investors a +1,105.93% return from current levels.
Tvardi Therapeutics, Inc. Monthly Forecast 2026
January 2026
According to our latest forecast models, Tvardi Therapeutics, Inc. (TVRD) is positioned to show a strong performance in January 2026. The price is predicted to move between $12.26 and $87.57, settling at an average of $61.09. This could translate to a +1,242.64% gain.
February 2026
Based on current market signals, Tvardi Therapeutics, Inc. is projected to trend february 2026. We forecast a trading range from $56.10 to $90.47, with a likely average price of $68.61. Investors could expect a potential return of +1,407.91%.
March 2026
Our predictive algorithms indicate Tvardi Therapeutics, Inc. stock may see a shift in March 2026. The expected range spans $50.11–$110.64, with an average target of $74.83. This represents a positive outlook and a possible gain of +1,544.62%.
April 2026
Analyzing established trends, Tvardi Therapeutics, Inc. looks set to move in April 2026. Projections place the stock between $50.13 and $79.72, averaging around $61.26. This suggests a +1,246.37% gain from current levels.
May 2026
Market indicators suggest Tvardi Therapeutics, Inc. could experience notable changes during May 2026. Prices could fluctuate within $81.08 to $101.49, with a midpoint forecast of $95.36. The stock might deliver a +1,995.82% gain.
June 2026
Forecasting for June 2026, models estimate that Tvardi Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $61.96 and $92.44, averaging $83.52. This signals a positive trajectory with potential returns around +1,735.60%.
July 2026
According to our latest forecast models, Tvardi Therapeutics, Inc. (TVRD) is positioned to show a strong performance in July 2026. The price is predicted to move between $61.81 and $87.82, settling at an average of $75.38. This could translate to a +1,556.70% gain.
August 2026
Based on current market signals, Tvardi Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $35.35 to $84.12, with a likely average price of $53.57. Investors could expect a potential return of +1,077.36%.
September 2026
Our predictive algorithms indicate Tvardi Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $36.41–$50.32, with an average target of $41.37. This represents a positive outlook and a possible gain of +809.23%.
October 2026
Analyzing established trends, Tvardi Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $39.99, averaging around $10.55. This suggests a +131.87% gain from current levels.
November 2026
Market indicators suggest Tvardi Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $18.77, with a midpoint forecast of $9.32. The stock might deliver a +104.84% gain.
December 2026
Forecasting for December 2026, models estimate that Tvardi Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $5.27 and $42.53, averaging $25.19. This signals a positive trajectory with potential returns around +453.63%.
TVRD's history of dividends and stock splits also plays a role in long-term investor confidence.